Cytori Therapeutics Amended S-1 Shows Registration For Offering: Subscription Rights To Buy Up To 25K Units Consisting Of Up To 25K Shares Of Series C Preferred Shares, Warrants To Buy Up To 5M Shares Of Common Stock
Benzinga Newsdesk